Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Phase 1 CAR T Cell Therapy Trial For Glioblastoma At City Of Hope, Demonstrates Clinical Activity Against Incurable Brain Tumors, The IL13Rα2-Targeting CAR T Cell Is Exclusively Licensed By Mustang Bio, A Fortress Biotech Company

Author: Benzinga Newsdesk | March 07, 2024 06:06am

Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response.
Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique City of Hope developed.
This is the largest reported trial to date of CAR T therapy for solid tumors.

Posted In: FBIO MBIO